Skip to content

Phase I/II trial of percutaneous vertebroplasty combined with radiotherapy for vertebral metastasis

Phase I/II trial of percutaneous vertebroplasty combined with radiotherapy for vertebral metastasis - Phase I/II trial of PVP+RT for vertebral metastasis

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000031321
Enrollment
36
Registered
2018-02-15
Start date
2018-03-31
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

vertebral metastasis

Interventions

Percutaneous vertebroplasty Radiation therapy 30Gy/3fr/10times, 20Gy/4fr/5times, or 8Gy/1fr/1time

Sponsors

Kobe University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)The terget lesion was diagnosed as vertebral metastasis. 2)The terget lesion was thoracic or lumber vertebrae. 3)The number of terget lesions was within 3.4)Bilsky Grade >= 1b 5)Patient has pain from the lesions under analgesic. 6)SINS >= 7 or SINS <= 6 and meet the below. a)Lytic lesions with > 1/3 vertebral body involved b)Lytic lesions with pain in mortion c)Lesions with vertebral collapse 7)The period of prognosis > 3 month

Exclusion criteria

Exclusion criteria: 1)Patients can not maintain the position needed for treatment 2)Target lesions is cervical vertebrae or sacrum 3)The number of terget lesions was more than 4. 4)Bilsky Grade >= 1c 5)History of radiation therapy or surgery for target lesions 6)Bleeding tendency (Platelet counts <= 50,000 or PT-INR > 1.5) 7)Spondylitis or discitis 8)History of major drug allergy

Design outcomes

Primary

MeasureTime frame
To evaluate short-time safety of percutaneous vertebroplasty combined with radiation therapy for vertebral metastasis with symptomatic skeletal events

Secondary

MeasureTime frame
To evaluate safety and efficacy of percutaneous vertebroplasty combined with radiation therapy for vertebral metastasis with symptomatic skeletal events

Countries

Japan

Contacts

Public ContactTakuya Okada

Kobe University Hospital Department of Diagnostic and Interventional Radiology

okataku@med.kobe-u.ac.jp078-382-6104

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026